冰山:一种新的干白素-1β生成抑制剂
E W Humke1, S K Shriver, M A Starovasnik
1Department of Cellular and Molecular Biology, University of Michigan Medical School, Ann Arbor 48109, USA.
Cell
|October 29, 2000
概括
冰山是一种新型蛋白质,通过结合caspase-1来抑制炎症性细胞因子IL-1beta的产生. 这一发现表明ICEBERG在炎症反应中起到负反机制的作用.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 抗炎性细胞因子IL-1beta是由酶-1激活的.
- RIP2适应蛋白在炎症刺激时促进caspase-1的自主激活.
- 调节IL-1β的产生对于控制炎症至关重要.
研究的目的:
- 为了确定IL-1β生成的新型调节剂.
- 为了阐明ICEBERG抑制IL-1β生成的机制.
- 描述ICEBERG-caspase-1相互作用的结构基础.
主要方法:
- 蛋白相互作用研究,以评估ICEBERG和caspase-1之间的结合.
- 逆转录病毒表达以研究ICEBERG在生物体中的功能作用.
- 进行X射线晶体学,以确定冰山的结构及其与caspase-1的复合体.
主要成果:
- ICEBERG直接与酶-1结合,防止其与RIP2结合并随后自动激活.
- 冰山表达是由促炎性刺激引起的,这表明负反作用.
- 强制ICEBERG表达抑制了脂多糖诱导的IL-1β生成.
- 结构分析显示,ICEBERG属于死亡域折叠超级家族,并通过电荷-电荷相互作用与caspase-1原域相互作用.
结论:
- ICEBERG 是一种新型的酶-1-介导IL-1β生成的抑制剂.
- 冰山在炎症途径中起到负反调节的作用.
- 结构和费用互补性解释了ICEBERG与caspase-1的特殊联系.
相关概念视频
Experimental RNAi
6.5K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
897
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
897
Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
Inhibitors of Bacterial Protein Synthesis
127
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
127
Inhibitors of Bacterial DNA Synthesis
163
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
163
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73


